Delivery Order SPE2DR25D2014-SPE2DR26FA5H7

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for Zepbound 15 mg/0.5 mL pen (tirzepatide injection), with a ceiling value of $3,214.64. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 6, 2026. This delivery order was issued under the parent IDC held by Cencora, Inc. (parent of AmerisourceBergen Drug Corp) with DLA Troop Support Medical, a $999,999,999...

The Defense Logistics Agency awarded a delivery order valued at $5,651.58 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pen injections. This firm fixed-price delivery order is scheduled for completion by January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation, reflecting the contractor's capability to meet federal...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (tirzepatide) 10 mg/0.5 mL pen injectors in 0.5 mL quantities, with a ceiling value of $1,906.45. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for completion by August 28, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injectors, with an order ceiling value of $16,756.44. This firm fixed price delivery order is set to be completed by September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pen injections with a ceiling value of $1,525.20. This competitive award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...

The Defense Logistics Agency awarded a $2,035.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 5 mg/0.5 ml pen injections. The contract has an ultimate completion date of January 7, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injectors valued at $7,436.99. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and involves performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pens with a ceiling value of $8,227.79. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injectors. This firm fixed-price delivery order, valued at $35,744.56, is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under...

The Defense Logistics Agency awarded a delivery order valued at approximately $30K to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pen injections on December 11, 2025. This competitively awarded, firm fixed-price delivery order is being fulfilled from the company's Conshohocken, Pennsylvania facility and is scheduled for completion by December 12, 2025. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This...